Image pharmaphorum Editor News Sanofi in final stages of negotiation in sale of generics ar... Sanofi is in the final stages of selling its European generics business, Zentiva, to private equity firm Advent International. Views & Analysis LHON diagnosis: Opening peoples’ eyes to the invisible suffe... Maryse Roger has firsthand experience of Leber’s hereditary optic neuropathy (LHON), having first assisted her two brothers as their sight deteriorated and then leading the care of her son News NHS ‘worse than average’ in treating common causes of death A report by four think tanks has concluded that the NHS is failing when it comes to treating eight of the 12 most common causes of death. News Wellcome Trust awards $8m cash injection to trial schizophre... The Wellcome Trust has awarded $8 million to PureTech’s Karuna to take its schizophrenia drug into mid-stage trials. Load more results
News Sanofi in final stages of negotiation in sale of generics ar... Sanofi is in the final stages of selling its European generics business, Zentiva, to private equity firm Advent International.
Views & Analysis LHON diagnosis: Opening peoples’ eyes to the invisible suffe... Maryse Roger has firsthand experience of Leber’s hereditary optic neuropathy (LHON), having first assisted her two brothers as their sight deteriorated and then leading the care of her son
News NHS ‘worse than average’ in treating common causes of death A report by four think tanks has concluded that the NHS is failing when it comes to treating eight of the 12 most common causes of death.
News Wellcome Trust awards $8m cash injection to trial schizophre... The Wellcome Trust has awarded $8 million to PureTech’s Karuna to take its schizophrenia drug into mid-stage trials.
News UK spurs prescribing of obesity jab Mounjaro with GP bonus Doctors in the UK will be given thousands of pounds in bonus payments from April for prescribing Eli Lilly's weight-loss drug Mounjaro.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
